The historical rank and industry rank for Ernexa Therapeutics's FCF Margin % or its related term are showing as below:
ERNA'
s FCF Margin % Range Over the Past 10 Years
Min: -30039.71 Med: -16412.04 Max: -2784.36
Current: -2784.36
During the past 5 years, the highest FCF Margin % of Ernexa Therapeutics was -2784.36%. The lowest was -30039.71%. And the median was -16412.04%.
ERNA's FCF Margin % is ranked worse than 85.47% of 1012
companies
in the Biotechnology industry
Industry Median: -131.635
vs ERNA: -2784.36
Ernexa Therapeutics FCF Margin % Historical Data
The historical data trend for Ernexa Therapeutics's FCF Margin % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Competitive Comparison of Ernexa Therapeutics's FCF Margin %
For the Biotechnology subindustry, Ernexa Therapeutics's FCF Margin %, along with its competitors' market caps and FCF Margin % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Ernexa Therapeutics's FCF Margin % Distribution in the Biotechnology Industry
For the Biotechnology industry and Healthcare sector, Ernexa Therapeutics's FCF Margin % distribution charts can be found below:
* The bar in red indicates where Ernexa Therapeutics's FCF Margin % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Ernexa Therapeutics FCF Margin % Related Terms
Thank you for viewing the detailed overview of Ernexa Therapeutics's FCF Margin % provided by GuruFocus.com. Please click on the following links to see related term pages.
Eterna Therapeutics Inc is a biopharmaceuticals company. The company develops transformational new medicines using various cell engineering technology. It is engaged in developing breakthrough mRNA cell engineering technologies to repair cellular dysfunction and treat a range of therapeutic indications. With its strategic partners, the group is developing nucleic acid and cell therapies that can significantly improve the health outcomes of patients with high unmet medical needs.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
Portfolio Contest
ERNA has been successfully added to your 